Applied DNA Sciences (NASDAQ:APDN) just reported results for the second quarter of 2024.
- Applied DNA Sciences reported earnings per share of -$2.71. This was above the analyst estimate for EPS of -$4.50.
- The company reported revenue of $929,631.
- This was 2.14% worse than the analyst estimate for revenue of $950,000.